{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T10:19:03Z","timestamp":1783333143453,"version":"3.54.6"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"DOI":"10.1007\/s12031-026-02553-6","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T07:14:55Z","timestamp":1781248495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploratory Analysis of Neuroimaging and Molecular Findings in a Cohort of Neuronal Ceroid Lipofuscinosis: a Descriptive study"],"prefix":"10.1007","volume":"76","author":[{"given":"Elham","family":"Rahimian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid. R.","family":"Tahsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohadeseh","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheyda","family":"Khalilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Aidin","family":"Farahvash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Reza","family":"Tavasoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golazin","family":"Shahbodagh Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Reza","family":"Ashrafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasan","family":"Saket","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Rahmanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Miryounesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soudeh","family":"Ghafouri-Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"issue":"4","key":"2553_CR11","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.ejrnm.2015.08.013","volume":"46","author":"EM Abdelsalam","year":"2015","unstructured":"Abdelsalam EM et al (2015) Proton MR Spectroscopy in leukodystrophies. Egypt J Radiol Nuclear Med 46(4):1091\u20131097","journal-title":"Egypt J Radiol Nuclear Med"},{"issue":"2","key":"2553_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0887-8994(92)90032-T","volume":"8","author":"T Autti","year":"1992","unstructured":"Autti T et al (1992) Jansky-Bielschowsky variant disease: CT, MRI, and SPECT findings. Pediatr Neurol 8(2):121\u2013126","journal-title":"Pediatr Neurol"},{"key":"2553_CR22","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/BF00607283","volume":"38","author":"T Autti","year":"1996","unstructured":"Autti T et al (1996) MRI of neuronal ceroid lipofuscinosis: I. Cranial MRI of 30 patients with juvenile neuronal ceroid lipofuscinosis. Neuroradiology 38:476\u2013482","journal-title":"Neuroradiology"},{"issue":"8","key":"2553_CR13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/acn3.222","volume":"2","author":"EH Baker","year":"2015","unstructured":"Baker EH et al (2015) Evaluation of disease progression in INCL by MR spectroscopy. Ann Clin Transl Neurol 2(8):797\u2013809","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"2553_CR27","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3174\/ajnr.A4978","volume":"38","author":"EH Baker","year":"2017","unstructured":"Baker EH et al (2017) MRI brain volume measurements in infantile neuronal ceroid lipofuscinosis. Am J Neuroradiol 38(2):376\u2013382","journal-title":"Am J Neuroradiol"},{"key":"2553_CR1","doi-asserted-by":"crossref","unstructured":"Bernardi S, Gemignani F, Marchese M (2023) The involvement of purkinje cells in progressive myoclonic epilepsy: focus on neuronal ceroid lipofuscinosis. Neurobiol Dis 185:106258","DOI":"10.1016\/j.nbd.2023.106258"},{"issue":"10","key":"2553_CR26","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.3174\/ajnr.A6726","volume":"41","author":"A Biswas","year":"2020","unstructured":"Biswas A et al (2020) Expanding the neuroimaging phenotype of neuronal ceroid lipofuscinoses. Am J Neuroradiol 41(10):1930\u20131936","journal-title":"Am J Neuroradiol"},{"issue":"2","key":"2553_CR31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.nic.2004.03.013","volume":"14","author":"S Blaser","year":"2004","unstructured":"Blaser S, Feigenbaum A (2004) A neuroimaging approach to inborn errors of metabolism. Neuroimaging Clin 14(2):307\u2013329","journal-title":"Neuroimaging Clin"},{"issue":"05","key":"2553_CR34","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1055\/s-2007-973772","volume":"27","author":"K Brockmann","year":"1996","unstructured":"Brockmann K et al (1996) Localized proton magnetic resonance spectroscopy of cerebral metabolic disturbances in children with neuronal ceroid lipofuscinosis. Neuropediatrics 27(05):242\u2013248","journal-title":"Neuropediatrics"},{"issue":"1","key":"2553_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0887-8994(93)90012-2","volume":"9","author":"S Confort-Gouny","year":"1993","unstructured":"Confort-Gouny S et al (1993) MRI and localized proton MRS in early infantile form of neuronal ceroid-lipofuscinosis. Pediatr Neurol 9(1):57\u201360","journal-title":"Pediatr Neurol"},{"issue":"1","key":"2553_CR12","doi-asserted-by":"publisher","first-page":"107584","DOI":"10.1016\/j.ymgme.2023.107584","volume":"139","author":"AN Dang Do","year":"2023","unstructured":"Dang Do AN et al (2023) Brain proton MR spectroscopy measurements in CLN3 disease. Mol Genet Metab 139(1):107584","journal-title":"Mol Genet Metab"},{"issue":"4","key":"2553_CR8","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/dmcn.14346","volume":"62","author":"B Dozi\u00e8res-Puyravel","year":"2020","unstructured":"Dozi\u00e8res-Puyravel B et al (2020) Paediatric\u2010onset neuronal ceroid lipofuscinosis: first symptoms and presentation at diagnosis. Dev Med Child Neurol 62(4):528\u2013530","journal-title":"Dev Med Child Neurol"},{"issue":"11","key":"2553_CR36","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1002\/humu.23860","volume":"40","author":"E Gardner","year":"2019","unstructured":"Gardner E et al (2019) Mutation update: Review of TPP1 gene variants associated with neuronal ceroid lipofuscinosis CLN2 disease. Hum Mutat 40(11):1924\u20131938","journal-title":"Hum Mutat"},{"key":"2553_CR35","first-page":"101060","volume":"38","author":"N Guelbert","year":"2024","unstructured":"Guelbert N et al (2024) Classic and Atypical Late Infantile Neuronal Ceroid Lipofuscinosis in Latin America: Clinical and Genetic Aspects, and Treatment Outcome with Cerliponase Alfa. Mol Genet Metabolism Rep 38:101060","journal-title":"Mol Genet Metabolism Rep"},{"issue":"4","key":"2553_CR29","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1212\/WNL.55.4.579","volume":"55","author":"V Holmberg","year":"2000","unstructured":"Holmberg V et al (2000) Phenotype\u2013genotype correlation in eight patients with Finnish variant late infantile NCL (CLN5). Neurology 55(4):579\u2013581","journal-title":"Neurology"},{"issue":"6","key":"2553_CR10","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1177\/197140091202500616","volume":"25","author":"R Jadav","year":"2012","unstructured":"Jadav R et al (2012) Magnetic resonance imaging in neuronal ceroid lipofuscinosis and its subtypes. Neuroradiol J 25(6):755\u2013761","journal-title":"Neuroradiol J"},{"issue":"2","key":"2553_CR33","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4103\/aian.AIAN_61_20","volume":"24","author":"M Kamate","year":"2021","unstructured":"Kamate M et al (2021) Neuronal Ceroid Lipofuscinoses in Children. Ann Indian Acad Neurol 24(2):192\u2013197","journal-title":"Ann Indian Acad Neurol"},{"issue":"10","key":"2553_CR4","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.3390\/ijms23105729","volume":"23","author":"K Kamini\u00f3w","year":"2022","unstructured":"Kamini\u00f3w K, Kozak S, Paprocka J (2022) Recent insight into the genetic basis, clinical features, and diagnostic methods for neuronal ceroid lipofuscinosis. Int J Mol Sci 23(10):5729","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2553_CR9","doi-asserted-by":"publisher","first-page":"e1228","DOI":"10.1002\/mgg3.1228","volume":"8","author":"AA Kozina","year":"2020","unstructured":"Kozina AA et al (2020) Neuronal ceroid lipofuscinosis in the Russian population: Two novel mutations and the prevalence of heterozygous carriers. Mol Genet Genom Med 8(7):e1228","journal-title":"Mol Genet Genom Med"},{"issue":"2","key":"2553_CR19","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/0149-936X(87)90010-5","volume":"11","author":"BC Machen","year":"1987","unstructured":"Machen BC et al (1987) Magnetic resonance imaging in neuronal ceroid lipofuscinosis. J Computed Tomography 11(2):160\u2013166","journal-title":"J Computed Tomography"},{"issue":"6663","key":"2553_CR15","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1126\/science.adg9288","volume":"381","author":"UN Medoh","year":"2023","unstructured":"Medoh UN et al (2023) The Batten disease gene product CLN5 is the lysosomal bis(monoacylglycero)phosphate synthase. Science 381(6663):1182\u20131189","journal-title":"Science"},{"issue":"9","key":"2553_CR7","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1177\/0883073813494268","volume":"28","author":"JW Mink","year":"2013","unstructured":"Mink JW et al (2013) Classification and natural history of the neuronal ceroid lipofuscinoses. J Child Neurol 28(9):1101\u20131105","journal-title":"J Child Neurol"},{"issue":"10","key":"2553_CR14","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/j.bbadis.2015.05.011","volume":"1852","author":"SE Mole","year":"2015","unstructured":"Mole SE, Cotman SL (2015) Genetics of the neuronal ceroid lipofuscinoses (Batten disease). Biochimica et Biophysica Acta (BBA)-Mol Basis Dis 1852(10):2237-2241","journal-title":"Biochimica et Biophysica Acta (BBA)-Mol. Basis Dis"},{"issue":"1","key":"2553_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1474-4422(18)30368-5","volume":"18","author":"SE Mole","year":"2019","unstructured":"Mole SE et al (2019) Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis. Lancet Neurol 18(1):107\u2013116","journal-title":"Lancet Neurol"},{"issue":"3","key":"2553_CR32","first-page":"215","volume":"5","author":"JA Pe\u00f1a","year":"2007","unstructured":"Pe\u00f1a JA et al (2007) MRI and proton spectroscopy in children with late infantile neuronal ceroid lipofuscinosis: preliminary results. J Pediatr Neurol 5(3):215\u2013220","journal-title":"J Pediatr Neurol"},{"issue":"2","key":"2553_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/13868","volume":"23","author":"S Ranta","year":"1999","unstructured":"Ranta S et al (1999) The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8. Nat Genet 23(2):233\u2013236","journal-title":"Nat Genet"},{"issue":"1","key":"2553_CR38","doi-asserted-by":"publisher","first-page":"18550","DOI":"10.1038\/s41598-023-45789-7","volume":"13","author":"C-M Rus","year":"2023","unstructured":"Rus C-M et al (2023) Neuronal progenitor cells-based metabolomics study reveals dysregulated lipid metabolism and identifies putative biomarkers for CLN6 disease. Sci Rep 13(1):18550","journal-title":"Sci Rep"},{"issue":"1","key":"2553_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.nbd.2011.12.009","volume":"46","author":"M-L Schmiedt","year":"2012","unstructured":"Schmiedt M-L et al (2012) Cln5-deficiency in mice leads to microglial activation, defective myelination and changes in lipid metabolism. Neurobiol Dis 46(1):19\u201329","journal-title":"Neurobiol Dis"},{"issue":"7","key":"2553_CR18","first-page":"1373","volume":"19","author":"D Seitz","year":"1998","unstructured":"Seitz D et al (1998) MR imaging and localized proton MR spectroscopy in late infantile neuronal ceroid lipofuscinosis. Am J Neuroradiol 19(7):1373\u20131377","journal-title":"Am J Neuroradiol"},{"key":"2553_CR5","doi-asserted-by":"publisher","first-page":"811686","DOI":"10.3389\/fneur.2022.811686","volume":"13","author":"A Simonati","year":"2022","unstructured":"Simonati A, Williams RE (2022) Neuronal ceroid lipofuscinosis: the multifaceted approach to the clinical issues, an overview. Front Neurol 13:811686","journal-title":"Front Neurol"},{"issue":"5","key":"2553_CR28","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/jnr.20123","volume":"77","author":"B Sitter","year":"2004","unstructured":"Sitter B et al (2004) High-resolution magic angle spinning and 1H magnetic resonance spectroscopy reveal significantly altered neuronal metabolite profiles in CLN1 but not in CLN3. J Neurosci Res 77(5):762\u2013769","journal-title":"J Neurosci Res"},{"key":"2553_CR39","unstructured":"Snell RS (2010) Clinical neuroanatomy. Lippincott Williams & Wilkins"},{"key":"2553_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s40265-020-01440-7","volume":"81","author":"N Specchio","year":"2021","unstructured":"Specchio N et al (2021) Neuronal ceroid lipofuscinosis: potential for targeted therapy. Drugs 81:101\u2013123","journal-title":"Drugs"},{"key":"2553_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/BF00369086","volume":"19","author":"A Valavanis","year":"1980","unstructured":"Valavanis A et al (1980) Computed tomography in neuronal ceroid lipofuscinosis. Neuroradiology 19:35\u201338","journal-title":"Neuroradiology"},{"issue":"8","key":"2553_CR17","first-page":"1443","volume":"15","author":"S-L Vanhanen","year":"1994","unstructured":"Vanhanen S-L, Raininko R, Santavuori P (1994) Early differential diagnosis of infantile neuronal ceroid lipofuscinosis, Rett syndrome, and Krabbe disease by CT and MR. Am J Neuroradiol 15(8):1443\u20131453","journal-title":"Am J Neuroradiol"},{"issue":"6","key":"2553_CR21","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1177\/088307389501000604","volume":"10","author":"S-L Vanhanen","year":"1995","unstructured":"Vanhanen S-L et al (1995) MRI evaluation of the brain in infantile neuronal ceroid-lipofuscinosis: part 2: MRI findings in 21 patients. J Child Neurol 10(6):444\u2013450","journal-title":"J Child Neurol"},{"issue":"01","key":"2553_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1055\/s-2004-815788","volume":"35","author":"S-L Vanhanen","year":"2004","unstructured":"Vanhanen S-L et al (2004) Neuroradiological findings (MRS, MRI, SPECT) in infantile neuronal ceroid-lipofuscinosis (infantile CLN1) at different stages of the disease. Neuropediatrics 35(01):27\u201335","journal-title":"Neuropediatrics"},{"issue":"2","key":"2553_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1212\/WNL.0b013e31825f0547","volume":"79","author":"RE Williams","year":"2012","unstructured":"Williams RE, Mole SE (2012) New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses. Neurology 79(2):183\u2013191","journal-title":"Neurology"},{"issue":"03","key":"2553_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1055\/s-2008-1071534","volume":"24","author":"K Wisniewski","year":"1993","unstructured":"Wisniewski K et al (1993) New subform of the late infantile form of neuronal ceroid lipofuscinosis. Neuropediatrics 24(03):155\u2013163","journal-title":"Neuropediatrics"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-026-02553-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-026-02553-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-026-02553-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:58:55Z","timestamp":1783331935000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-026-02553-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["2553"],"URL":"https:\/\/doi.org\/10.1007\/s12031-026-02553-6","relation":{},"ISSN":["1559-1166"],"issn-type":[{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the ethics committee of Shahid Beheshti University of Medical Sciences, Tehran, Iran (IR.SBMU.MSP.REC.1400.250). All procedures involving human participants in this study were conducted by the ethical standards of the institutional research committee (Clinical Research Adoption Committee) and the 1964 Helsinki Declaration, as well as its subsequent amendments or comparable ethical standards. Informed consent forms were signed by patients or their guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"Informed consent forms allowing publication of relevant data were signed by patients or their guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}